v3.26.1
STOCKHOLDERS’ DEFICIT
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE 7. STOCKHOLDERS’ DEFICIT

 

Common Stock

 

As of March 31, 2026, the Company had 4,168,705 shares of common stock issued and outstanding. For accounting purposes related to earnings per share, only shares that are fully vested are considered issued and outstanding.

 

Below is a reconciliation of shares of common stock issued and outstanding:

 

   March 31, 2026 
Total shares of common stock issued and outstanding   4,168,705 
Plus: shares to be issued:     
Vested RSUs not yet legally settled into common stock (a)   8,425 
Less: Shares subject to future vesting:     
Issuance of restricted common stock subject to forfeiture (b)   (571,979)
Total shares, net   3,605,151 

 

(a) As of March 31, 2026, there were RSUs that had vested but had not been legally settled into common stock.
   
(b) The Company’s executive officers will automatically forfeit all unvested Restricted Stock in the event they depart the Company.

 

Public Warrants

 

As of March 31, 2026, there are 17,386,580 public warrants outstanding.

 

Private Placement Warrants

 

As of March 31, 2026, there are 588,398 private placement warrants outstanding.

 

See Note 3 for additional information on the Company’s warrant accounting policy.